| Immunoregulatory roles of versican proteolysis in the myeloma microenvironment C Hope, S Foulcer, J Jagodinsky, SX Chen, JL Jensen, S Patel, C Leith, ... Blood, The Journal of the American Society of Hematology 128 (5), 680-685, 2016 | 141 | 2016 |
| The promise of combining radiation therapy with immunotherapy JC Jagodinsky, PM Harari, ZS Morris International Journal of Radiation Oncology* Biology* Physics 108 (1), 6-16, 2020 | 120 | 2020 |
| Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade RB Patel, R Hernandez, P Carlson, J Grudzinski, AM Bates, ... Science translational medicine 13 (602), eabb3631, 2021 | 109 | 2021 |
| Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy JC Jagodinsky, WJ Jin, AM Bates, R Hernandez, JJ Grudzinski, IR Marsh, ... Theranostics 11 (13), 6120, 2021 | 42 | 2021 |
| Quantification and molecular imaging of fatty acid isomers from complex biological samples by mass spectrometry H Zhang, M Xu, X Shi, Y Liu, Z Li, JC Jagodinsky, M Ma, NV Welham, ... Chemical science 12 (23), 8115-8122, 2021 | 34 | 2021 |
| Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade Y Zhang, RN Sriramaneni, PA Clark, JC Jagodinsky, M Ye, W Jin, Y Wang, ... Nature Communications 13 (1), 4948, 2022 | 29 | 2022 |
| Priming and propagating anti-tumor immunity: Focal hypofractionated radiation for in situ vaccination and systemic targeted radionuclide theranostics for immunomodulation of … JC Jagodinsky, ZS Morris Seminars in radiation oncology 30 (2), 181-186, 2020 | 26 | 2020 |
| Tumor-Specific Antibody, Cetuximab, Enhances the In Situ Vaccine Effect of Radiation in Immunologically Cold Head and Neck Squamous Cell Carcinoma WJ Jin, AK Erbe, CN Schwarz, AA Jaquish, BR Anderson, ... Frontiers in Immunology 11, 591139, 2020 | 24 | 2020 |
| Characterizing the binding interactions between P‐glycoprotein and eight known cardiovascular transport substrates JC Jagodinsky, U Akgun Pharmacology Research & Perspectives 3 (2), e00114, 2015 | 23 | 2015 |
| Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs JC Jagodinsky, A Sulima, Y Cao, JE Poprawski, BN Blackman, JR Lloyd, ... JBIC Journal of Biological Inorganic Chemistry 20, 1081-1095, 2015 | 22 | 2015 |
| Cardiac toxicity in operable esophageal cancer patients treated with or without chemoradiation JS Witt, JC Jagodinsky, Y Liu, P Yadav, A Kuczmarska-Haas, M Yu, ... American journal of clinical oncology 42 (8), 662-667, 2019 | 19 | 2019 |
| Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor Models AA Pieper, LM Zangl, DV Speigelman, AS Feils, A Hoefges, ... Frontiers in Immunology 12, 763888, 2021 | 13 | 2021 |
| Local TLR4 stimulation augments in situ vaccination induced via local radiation and anti-CTLA-4 checkpoint blockade through induction of CD8 T-cell independent Th1 polarization JC Jagodinsky, AM Bates, PA Clark, RN Sriramaneni, TC Havighurst, ... Journal for Immunotherapy of Cancer 10 (10), 2022 | 11 | 2022 |
| Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain PA Clark, RN Sriramaneni, AM Bates, WJ Jin, JC Jagodinsky, ... Radiation research 195 (6), 522-540, 2021 | 11 | 2021 |
| In situ vaccination at a peripheral tumor site augments response against melanoma brain metastases PA Clark, RN Sriramaneni, WJ Jin, JC Jagodinsky, AM Bates, AA Jaquish, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 8 | 2020 |
| Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade. Sci Transl Med 2021; 13 (602) RB Patel, R Hernandez, P Carlson, J Grudzinski, AM Bates, ... DOI: https://doi. org/10.1126/scitranslmed. abb3631, 0 | 7 | |
| Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy. Theranostics. 2021; 11: 6120–37 JC Jagodinsky, WJ Jin, AM Bates, R Hernandez, JJ Grudzinski, IR Marsh, ... DOI: https://doi. org/10.7150/thno 54881, 6120-6137, 0 | 5 | |
| Mechanistic insights into combination low dose targeted radionuclide and checkpoint blockade treatment to turn a" cold" tumor" hot" R Patel, R Hernandez, P Carlson, R Brown, L Zangl, A Bates, I Arthur, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | 3 | 2019 |
| Bempegaldesleukin (NKTR-214), a CD122 preferential IL-2 pathway agonist, augments the in situ vaccine response to radiation of an extracranial tumor in a … PA Clark, RN Sriramaneni, A Pieper, AM Bates, BR Anderson, W Jin, ... Cancer Research 80 (16_Supplement), 4440-4440, 2020 | 2 | 2020 |
| NK cells propagate T cell immunity following in situ tumor vaccination WJ Jin, JC Jagodinsky, JM Vera, PA Clark, CL Zuleger, AK Erbe, IM Ong, ... Cell reports 42 (12), 2023 | 1 | 2023 |
Matthew D HallNational Center for Advancing Translational Sciences (NCATS)Verified email at mail.nih.gov
